Preferred Label : Prognostic Stage IIIA Breast Cancer AJCC v8;
NCIt synonyms : Prognostic Stage IIIA Breast Carcinoma AJCC v8;
NCIt related terms : Stage IIIA Breast Cancer;
NCIt definition : Stage IIIA includes: (T0-1, N1, M0, G2, HER2 Status: Negative, ER Status: Negative,
PR Status: Negative); (T0-1, N1, M0, G3, HER2 Status: Negative, ER Status: Positive,
PR Status: Negative); (T0-1, N1, M0, G3, HER2 Status: Negative, ER Status: Negative,
PR Status: Any); (T2, N0, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status:
Negative); (T2, N0, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status:
Negative); (T2, N0, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status:
Any); (T2, N1, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative);
(T2, N1, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Negative);
(T2, N1, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative);
(T2, N1, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative);
(T2, N1, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Negative);
(T3, N0, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative);
(T3, N0, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Negative);
(T3, N0, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative);
(T3, N0, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative);
(T3, N0, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Negative);
(T0-2, N2, M0, G1, HER2 Status: Positive, ER Status: Positive, PR Status: Negative);
(T0-2, N2, M0, G1, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T0-2,
N2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-2,
N2, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-2,
N2, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); ( T0-2,
N2, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T3, N1-2,
M0, G1, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T3, N1-2,
M0, G1, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T3, N1-2, M0,
G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0,
G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T3, N1-2, M0,
G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0,
G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T4, N0-2, M0, G1,
HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (Any T, N3, M0,
G1, HER2 Status: Negative, ER Status: Positive, PR Status: Positive). T0: No evidence
of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor
measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor
measuring more than 50 mm in greatest dimension. T4: Tumor of any size with direct
extension to the chest wall and/or to the skin (ulceration or macroscopic nodules);
invasion of the dermis alone does not qualify as T4. N0: No regional lymph node metastasis
is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor
with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically
negative internal mammary nodes with micrometastases or macrometastases by sentinel
lymph node biopsy. N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive
ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph
node metastases. N3: Tumor with metastases in 10 or more axillary lymph nodes; or
in infraclavicular (level III axillary) lymph nodes; or positive ipsilateral internal
mammary lymph nodes by imaging in the presence of one or more positive level I, II
axillary lymph nodes; or in more than three axillary lymph nodes and micrometastases
or macrometastases by sentinel lymph node biopsy in clinically negative ipsilateral
internal mammary lymph nodes; or in ipsilateral supraclavicular lymph nodes. G1: Low
combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined
histologic grade ...;
Neoplastic status : Malignant;
NCI Metathesaurus CUI : CL526882;
Origin ID : C139583;
UMLS CUI : C4528589;
Disease excludes abnormal cell
- Has associated anatomic sites
- Semantic type(s)
- concept_is_in_subset
- disease_excludes_finding
- disease_has_abnormal_cell
- disease_has_finding
- disease_has_normal_cell_origin
- disease_has_normal_tissue_origin
- disease_has_primary_anatomic_site
- disease_is_stage
